abstract |
The present invention relates to a co-micronization product comprising an active ingredient selected from the group consisting of ulipristal acetate, a metabolite of ulipristal acetate and mixtures thereof, and a pharmaceutically acceptable solid surfactant. The invention also relates to a pharmaceutical composition comprising said co-micronization product and its therapeutic uses. |